Monday, April 06, 2020 9:05:35 PM
here is something else that could be helpful:
Source (look under rule 27)
http://www.cafc.uscourts.gov/sites/default/files/rules-of-practice/ProposedRules/federal_circuit_rules_public_notice_dec_2015.pdf
MOTION TO EXPEDITE PROCEEDINGS. While motions to expedite proceedings are not
routinely granted, they may be filed in an appropriate case. A motion for expedited proceedings is
the procedural vehicle to request the court to accelerate consideration of an appeal or petition for
review, and should be filed immediately upon filing of an appeal or petition for review. Such a motion
is appropriate where the normal briefing and disposition schedule may adversely affect one of the
parties, such as appeals involving preliminary or permanent injunctions, or government contract bid
protests. A motion for expedited proceedings should be styled as an “Emergency Motion.” Unopposed
emergency motions should still include a brief review of the grounds for the motion, the specific relief
sought by way of a proposed briefing schedule, and the legal argument to support the motion, per
Rule 27(a)(4). A motion for expedited proceedings should also include as part of the relief sought a
request for an expedited briefing schedule for the motion.
Source (look under rule 27)
http://www.cafc.uscourts.gov/sites/default/files/rules-of-practice/ProposedRules/federal_circuit_rules_public_notice_dec_2015.pdf
MOTION TO EXPEDITE PROCEEDINGS. While motions to expedite proceedings are not
routinely granted, they may be filed in an appropriate case. A motion for expedited proceedings is
the procedural vehicle to request the court to accelerate consideration of an appeal or petition for
review, and should be filed immediately upon filing of an appeal or petition for review. Such a motion
is appropriate where the normal briefing and disposition schedule may adversely affect one of the
parties, such as appeals involving preliminary or permanent injunctions, or government contract bid
protests. A motion for expedited proceedings should be styled as an “Emergency Motion.” Unopposed
emergency motions should still include a brief review of the grounds for the motion, the specific relief
sought by way of a proposed briefing schedule, and the legal argument to support the motion, per
Rule 27(a)(4). A motion for expedited proceedings should also include as part of the relief sought a
request for an expedited briefing schedule for the motion.
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
